PHIO

Phio Pharmaceuticals Corp.

0.80 USD
+0.01 (+1.41%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Phio Pharmaceuticals Corp. stock is up 24.69% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 12 May’s closed higher than April. 100% of analysts rate it a buy.

About Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. Company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint protein PD-1 for immunotherapy in adoptive cell transfer (ACT) PH-894 that silences the epigenetic protein BRD4, which is an intracellular regulator of gene expression.